ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies

BKA Dayyeh, N Kumar, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …

[HTML][HTML] Role of endoscopic vacuum therapy in the management of gastrointestinal transmural defects

DTH de Moura, BFBH de Moura… - World Journal of …, 2019 - ncbi.nlm.nih.gov
A gastrointestinal (GI) transmural defect is defined as total rupture of the GI wall, and these
defects can be divided into three categories: perforations, leaks, and fistulas. Surgical …

Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients

RZ Sharaiha, NA Kumta, M Saumoy, AP Desai… - Clinical …, 2017 - Elsevier
Background & Aims Endoscopic sleeve gastroplasty (ESG) is an incisionless, minimally
invasive bariatric procedure that reduces the length and width of the gastric cavity to …

Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international …

A Sartoretto, Z Sui, C Hill, M Dunlap, AR Rivera… - Obesity Surgery, 2018 - Springer
Objective Endoscopic sleeve gastroplasty (ESG), an incisionless endoscopic bariatric
procedure, has shown impressive results in case series. This study examines the …

Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial

A Courcoulas, BK Abu Dayyeh, L Eaton… - International journal of …, 2017 - nature.com
Results: At 6 months, weight loss was− 3.3% of total body weight (− 3.2 kg) in the lifestyle
arm vs− 10.2%(− 9.9 kg) in the balloon plus lifestyle arm (P< 0.001); at 9 months (3 months …

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies

ABET Force, BKA Dayyeh, N Kumar… - Gastrointestinal …, 2015 - pubmed.ncbi.nlm.nih.gov
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …

[HTML][HTML] Current status of intragastric balloon for obesity treatment

SH Kim, HJ Chun, HS Choi, ES Kim… - World journal of …, 2016 - ncbi.nlm.nih.gov
Endoscopic bariatric therapy may be a useful alternative to pharmacological treatment for
obesity, and it provides greater efficacy with lower risks than do conventional surgical …

The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes

G López-Nava, I Bautista-Castaño, A Jimenez… - Surgery for Obesity and …, 2015 - Elsevier
Background Obesity is at epidemic proportions and increasing. Bariatric surgical procedures
have demonstrated better durable weight loss than diet and exercise; however, risk may limit …

Early experience with the Incisionless Operating Platform™(IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure

JC Espinós, R Turró, A Mata, M Cruz, M Da Costa… - Obesity surgery, 2013 - Springer
Background We report our initial experience and 6-month outcomes in a single center using
the per-oral Incisionless Operating Platform™(IOP)(USGI Medical) to place transmural …

Endoscopic bariatric therapies

BKA Dayyeh, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
BACKGROUND More than one-third of US adults are obese. 1 The increasing prevalence of
obesity in the United States has been accompanied by an increasing prevalence in its …